Every day EIT Health innovation projects, education programmes and entrepreneurship activities are catalysing healthcare innovation across Europe. As a recognition of their work and achieved milestones, each year the EIT rewards the most promising projects by naming them as “Success Stories“. Among the many successes in healthcare innovation supported by EIT Health in 2020, 11 “Success Stories” have been approved as outstanding examples of the work we do by the European Institute of Innovation and Technology.
Like all EIT Health successes, these 11 activities and people promise to make critical improvements in healthcare for citizens and patients in Europe, and beyond. The EIT has singled them out for special recognition based on specific criteria, including their achievement of excellence thanks to EIT Health support.
Moving closer to home, three Success Stories come from our portfolio so let’s take a closer look at them.
ViruShield project (2020 Rapid Response Project Call): As part of the EIT Health COVID-19 Rapid Response Initiative, with the objective to discover alternative filter materials for face masks, the researchers at the ITA of RWTH Aachen University and at the Freie Universität Berlin achieved great results. While researchers at the ITA of RWTH Aachen University conducted experiments on the chemical and physical properties of various textiles for face masks, researchers at Freie Universität Berlin were able to demonstrate that these new textiles can reduce high amounts of SARS-CoV-2 virus particles by up to 99.9% within a few hours.
Mecasa (EIT Health Headstart programme 2019 and has also benefited from the EIT Health Mentorship and Coaching Network): A new quality standard DIN SPEC 33454 was published by the German Institute for Standardization (DIN), which has been developed under the direction of the start-up Mecasa by an interdisciplinary committee. This quality standard for higher quality 24h care by Mecasa provides an important impetus for legal and social balance and is intended to provide standardized protection for clients and caregivers alike.
Spindiag (EIT Health Catapult 2017): Spindiag closed a Series B financing round of €16.3 million, intended for the market launch of the Rhonda diagnostic platform for the detection of the Sars-CoV-2 virus. The Rhonda “mini-lab” was designed with decentralized settings in mind to enable simple and reliable testing at the point of care. It applies a two-step polymerase chain reaction (PCR) test, which represents an advantageous variation of the laboratory gold standard PCR test and provides test results about a coronavirus infection in approximately 30 to 40 minutes.
Congratulations to the rest of teams, projects, start-ups and partners for their success!